Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by wildbird1on Apr 27, 2020 11:00am
1252 Views
Post# 30957422

RE:RE:RE:Darren R comments that were posted on Yahoo Board

RE:RE:RE:Darren R comments that were posted on Yahoo BoardAgree, he also said we are working at an unprecedent rate, meaning fast traking could be coming faster than we expect.

NothinButTime wrote:

I think he is addressing people that keep saying "I thought this was being fast tracked"   

He is pointing out that it usually takes 12-18 i this and it IS being fast tracked seeing as they are in the final stages. 

Great find WM from the comment section of another post.  Thanks for sharing


 

Pandora wrote: He could have left out the 12 - 18 month remark and been just as effective. Throwing that in just plays on some peoples minds.

 

 

wm23four wrote: Found these comments from Darren R on Yahoo board.  A poster on that forum was concerned about the comments Darren had posted on twitter.  They emailed Darren for clarification and  Darren emailed back.  His comments pretty much coincide with what shoosh an nothinbuttime were thinking after analysis, as Darren comments were inititally sort of ambiguous.

"I emailed him for clarification. Here is his response. Thanks for your message.
My tweet was to clarify the general process that all LF test developments are likely to go through.

Typically you start with a range of target antibodies/antigens/affirmers/aptamers which are screened to a select few.
These are then tested in a prototype design to find the best fit. Optimisation of those formats then takes place and prior to validation in clinical settings and trials with patients samples.

I can’t comment on the status of anyone else’s test of course.
The ‘screen down to 3 or 4’ from the tweet relates to the start of the development process in general -ie) if your starting with say 50 reagents.

Sona moved beyond the screening/prototype stages recently and are now into optimisation/validation phase to ensure we obtain the best results possible within the short timeframe that we set ourselves. We are also already engaged with our manufacturers and suppliers to ensure a swift transfer into manufacture occurs, once testing is completed.

It is important to note that typically such developments take place over 12-18 months to allow for screening, testing, optimisation of multiple scenarios and combinations of biologicals and tests materials/housing etc. We are moving at an unprecedented rate, working everyday to bring this to fruition in record time.

I hope this clarify’s your points and provides understanding of the wider process.

Thank you for your support of Sona
Kind regards
Darren."

wm  

 




Bullboard Posts